Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.
Proc Natl Acad Sci U S A.
2006 Jan 3;103(1):177-82. doi: 10.1073/pnas.0506803102. Epub 2005 Dec 21. PubMed PMID:
16371473; PubMed Central PMCID:
PMC1324982.
Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria.
J Commun Dis.
2006 Mar;38(3):230-45. PubMed PMID:
17373355.
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.
Emerg Infect Dis.
2016 Aug;22(8):1381-6. doi: 10.3201/eid2208.151905. PubMed PMID:
27434054; PubMed Central PMCID:
PMC4982175.
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry.
Eur Heart J Qual Care Clin Outcomes.
2019 Jul 1;5(3):202-207. doi: 10.1093/ehjqcco/qcz018. PubMed PMID:
30957862.
Incidence of healthcare-associated Clostridioides difficile infections and association with ward-level antibiotic consumption in a German university hospital: an ecological study.
J Antimicrob Chemother.
2019 Aug 1;74(8):2400-2404. doi: 10.1093/jac/dkz195. PubMed PMID:
31098633.
Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children.
Medicine (Baltimore).
2019 Sep;98(38):e17185. doi: 10.1097/MD.0000000000017185. PubMed PMID:
31567961; PubMed Central PMCID:
PMC6756729.
Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study.
Pediatr Infect Dis J.
2019 Nov;38(11):e295-e300. doi: 10.1097/INF.0000000000002417. PubMed PMID:
31626041.
Antibiotikatherapie (2): Ambulante parenterale Gabe.
Dtsch Arztebl - SUPPLEMENT: Perspektiven der Infektiologie. 2019; (116):29-30.
Aktuelles zur Chagas-Krankheit und das deutsche Chagas-Netzwerk ELCiD.
Flugmedizin · Tropenmedizin · Reisemedizin -FTR. 2019; 26(01):25-30. doi: 10.1055/a-0822-0315.
[Antibiotic Stewardship in Community-Acquired Pneumonia].
Dtsch Med Wochenschr.
2020 Mar;145(6):383-392. doi: 10.1055/a-0993-1164. Epub 2020 Mar 19. Review. PubMed PMID:
32191978.
Outpatient decolonization after recurrent skin infection with Panton-Valentine leukocidin (PVL)-producing S. aureus-The importance of treatment repetition.
PLoS One.
2020;15(4):e0231772. doi: 10.1371/journal.pone.0231772. eCollection 2020. PubMed PMID:
32315364; PubMed Central PMCID:
PMC7173765.
How emergency departments prepare for virus disease outbreaks like COVID-19.
Eur J Emerg Med.
2020 Jun;27(3):161-162. doi: 10.1097/MEJ.0000000000000703. PubMed PMID:
32224710; PubMed Central PMCID:
PMC7202109.
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).
Infection.
2020 Aug;48(4):619-626. doi: 10.1007/s15010-020-01464-x. Epub 2020 Jun 13. PubMed PMID:
32535877; PubMed Central PMCID:
PMC7293426.
Seltene Pilzinfektionen der Lunge, Rare fungal infections of the lung.
Der Pneumologe. 2020 June. doi: 10.1007/s10405-020-00332-7.
Outpatient treatment of imported uncomplicated Plasmodium falciparum malaria: results from a survey among TropNet and GeoSentinel experts for tropical medicine.
J Travel Med.
2020 Jul 14;27(4). doi: 10.1093/jtm/taaa082. PubMed PMID:
32442249.
HIV transmission by human bite: a case report and review of the literature-implications for post-exposure prophylaxis.
Infection.
2020 Dec;48(6):949-954. doi: 10.1007/s15010-020-01477-6. Epub 2020 Jul 26. Review. PubMed PMID:
32715389; PubMed Central PMCID:
PMC7674319.
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
Cell.
2020 Sep 17;182(6):1419-1440.e23. doi: 10.1016/j.cell.2020.08.001. Epub 2020 Aug 5. PubMed PMID:
32810438; PubMed Central PMCID:
PMC7405822.
Heterogeneous approach to nebulization of antimicrobial agents in mechanically ventilated adults in a German tertiary care hospital: a cross-sectional survey.
Eur J Clin Microbiol Infect Dis.
2021 Feb;40(2):419-421. doi: 10.1007/s10096-020-04017-0. Epub 2020 Sep 3. PubMed PMID:
32885292; PubMed Central PMCID:
PMC7471553.
A living WHO guideline on drugs for covid-19.
BMJ.
2020 Sep 4;370:m3379. doi: 10.1136/bmj.m3379. PubMed PMID:
32887691.
[New developments in outpatient parenteral antibiotic therapy (OPAT)].
Dtsch Med Wochenschr.
2020 Nov;145(23):1688-1694. doi: 10.1055/a-1114-3990. Epub 2020 Nov 17. PubMed PMID:
33202453.
[Rare infections of the lungs not endemic in Germany].
Pneumologe (Berl).
2020;17(6):477-488. doi: 10.1007/s10405-020-00352-3. Epub 2020 Nov 3. PubMed PMID:
33162874; PubMed Central PMCID:
PMC7607892.
Update to living WHO guideline on drugs for covid-19.
BMJ.
2020 Nov 19;371:m4475. doi: 10.1136/bmj.m4475. PubMed PMID:
33214213.
Update to living WHO guideline on drugs for covid-19.
BMJ.
2020 Dec 17;371:m4779. doi: 10.1136/bmj.m4779. PubMed PMID:
33334781.
WHO COVID-19 Clinical management: living guidance.
WHO/2019-nCoV/clinical/2021.1. 2021 January.
Rothia aeria and Rothia dentocariosa as biofilm builders in infective endocarditis.
Int J Med Microbiol.
2021 Feb;311(2):151478. doi: 10.1016/j.ijmm.2021.151478. Epub 2021 Feb 6. PubMed PMID:
33581548.
Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19.
Kidney Int Rep.
2021 Apr;6(4):905-915. doi: 10.1016/j.ekir.2021.01.011. Epub 2021 Feb 2. PubMed PMID:
33817450; PubMed Central PMCID:
PMC8007085.
SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
Biomarkers.
2021 May;26(3):213-220. doi: 10.1080/1354750X.2021.1876769. Epub 2021 Feb 18. PubMed PMID:
33455451; PubMed Central PMCID:
PMC7898296.
A living WHO guideline on drugs to prevent covid-19.
BMJ.
2021 Mar 1;372:n526. doi: 10.1136/bmj.n526. PubMed PMID:
33649077.
Which parameters support disposition decision in suspected COVID-19 cases in the emergency department (ED): a German clinical cohort study.
BMJ Open.
2021 Mar 31;11(3):e044853. doi: 10.1136/bmjopen-2020-044853. PubMed PMID:
33789854; PubMed Central PMCID:
PMC8015792.
Update to living WHO guideline on drugs for covid-19.
BMJ.
2021 Mar 31;372:n860. doi: 10.1136/bmj.n860. PubMed PMID:
33789884.
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.
Infection.
2021 Aug;49(4):757-762. doi: 10.1007/s15010-021-01606-9. Epub 2021 Apr 6. PubMed PMID:
33825125; PubMed Central PMCID:
PMC8023546.
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study.
Infection.
2021 Aug;49(4):703-714. doi: 10.1007/s15010-021-01594-w. Epub 2021 Apr 22. PubMed PMID:
33890243; PubMed Central PMCID:
PMC8061715.
Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
Cochrane Database Syst Rev.
2021 May 24;5(5):CD015043. doi: 10.1002/14651858.CD015043. PubMed PMID:
34029377; PubMed Central PMCID:
PMC8406457.
A time-resolved proteomic and prognostic map of COVID-19.
Cell Syst.
2021 Aug 18;12(8):780-794.e7. doi: 10.1016/j.cels.2021.05.005. Epub 2021 Jun 14. PubMed PMID:
34139154; PubMed Central PMCID:
PMC8201874.
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study.
Clin Microbiol Infect.
2021 Oct;27(10):1520.e7-1520.e10. doi: 10.1016/j.cmi.2021.06.008. Epub 2021 Jun 15. PubMed PMID:
34139335; PubMed Central PMCID:
PMC8205283.
Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus-Cost effectiveness of outpatient treatment.
PLoS One.
2021;16(6):e0253633. doi: 10.1371/journal.pone.0253633. eCollection 2021. PubMed PMID:
34170945; PubMed Central PMCID:
PMC8232536.
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).
Infection.
2022 Feb;50(1):93-106. doi: 10.1007/s15010-021-01645-2. Epub 2021 Jul 6. PubMed PMID:
34228347; PubMed Central PMCID:
PMC8259552.
Update to living WHO guideline on drugs for covid-19.
BMJ.
2021 Jul 6;374:n1703. doi: 10.1136/bmj.n1703. PubMed PMID:
34230027.
Ivermectin for preventing and treating COVID-19.
Cochrane Database Syst Rev.
2021 Jul 28;7(7):CD015017. doi: 10.1002/14651858.CD015017.pub2. PubMed PMID:
34318930; PubMed Central PMCID:
PMC8406455.
Remdesivir for the treatment of COVID-19.
Cochrane Database Syst Rev.
2021 Aug 5;8(8):CD014962. doi: 10.1002/14651858.CD014962. PubMed PMID:
34350582; PubMed Central PMCID:
PMC8406992.
Systemic corticosteroids for the treatment of COVID-19.
Cochrane Database Syst Rev.
2021 Aug 16;8(8):CD014963. doi: 10.1002/14651858.CD014963. PubMed PMID:
34396514; PubMed Central PMCID:
PMC8406706.
Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges.
BMJ Evid Based Med.
2022 Jun;27(3):187-188. doi: 10.1136/bmjebm-2021-111791. Epub 2021 Aug 20. PubMed PMID:
34417268; PubMed Central PMCID:
PMC9132871.
Colchicine for the treatment of COVID-19.
Cochrane Database Syst Rev.
2021 Oct 18;10(10):CD015045. doi: 10.1002/14651858.CD015045. PubMed PMID:
34658014; PubMed Central PMCID:
PMC8521385.
Antibiotics for the treatment of COVID-19.
Cochrane Database Syst Rev.
2021 Oct 22;10(10):CD015025. doi: 10.1002/14651858.CD015025. PubMed PMID:
34679203; PubMed Central PMCID:
PMC8536098.
Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing-A Translational Example for Intensive Care Units.
Pharmaceutics.
2021 Dec 10;13(12). doi: 10.3390/pharmaceutics13122128. PubMed PMID:
34959409; PubMed Central PMCID:
PMC8708464.
Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis.
J Clin Med.
2021 Dec 23;11(1). doi: 10.3390/jcm11010057. Review. PubMed PMID:
35011804; PubMed Central PMCID:
PMC8745419.
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients.
Crit Care.
2022 Jan 28;26(1):30. doi: 10.1186/s13054-022-03902-8. PubMed PMID:
35090528; PubMed Central PMCID:
PMC8796178.
Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).
Infection.
2022 Feb;50(1):107-108. doi: 10.1007/s15010-021-01665-y. PubMed PMID:
34414563; PubMed Central PMCID:
PMC8375461.
Preparing for patients with high-consequence infectious diseases: Example of a high-level isolation unit.
PLoS One.
2022;17(3):e0264644. doi: 10.1371/journal.pone.0264644. eCollection 2022. PubMed PMID:
35239726; PubMed Central PMCID:
PMC8893674.
Inhaled corticosteroids for the treatment of COVID-19.
Cochrane Database Syst Rev.
2022 Mar 9;3(3):CD015125. doi: 10.1002/14651858.CD015125. PubMed PMID:
35262185; PubMed Central PMCID:
PMC8905579.
What would you like to do?